Investor presentations

RNS Number : 7722R
Silver Falcon PLC
26 September 2017
 

Silver Falcon Plc

(to become Hemogenyx Pharmaceuticals Plc)

 

Investor presentations

 

Silver Falcon Plc, (LSE: SILF), which has agreed to acquire the biotechnology company Hemogenyx Pharmaceuticals Limited ("Hemogenyx"), announces that it will be holding a series of meetings with investors regarding the opportunity presented to shareholders by the proposed acquisition of Hemogenyx LLC ("Hemogenyx").

 

The presentation will be led by Chief Executive Officer & Co-Founder of Hemogenyx, Dr Vladislav Sandler, with other Proposed Directors available for discussions after the formal presentation. The same presentation will be given at all events which are being held at different times to offer convenient options for those wishing to attend.

 

3 October 2017 - Lunchtime presentation hosted by Peterhouse Corporate Finance Limited

Time:

12.30pm - a sandwich lunch will be provided

Location:

3rd Floor New Liverpool House, 15 Eldon Street, London EC2M 7LD

 

3 October 2017 - Afternoon Presentation hosted by Shard Capital Partners LLP

Time:

5pm - the presentation will be followed by drinks and canapes

Location:

23rd Floor, 20 Fenchurch Street, London EC3M 3BY

 

4 October 2017 - Evening presentation hosted by Optiva Securities Limited

Time:

6pm - the presentation will be followed by drinks and canapes

Location:

Sartoria, 20 Savile Row, London W1S 3PR

 

 

For more information on the proposed acquisition see the Latest News section on: www.silverfalconplc.com

 

For a short video by Dr Sandler on Hemogenyx click here: www.brrmedia.co.uk/event/160159

 

If you would like to register for any of the investor presentations, or require further information, please contact Lianne Cawthorne at Walbrook PR on 020 7933 8780 or email hemogenyx@walbrookpr.com ensuring you detail in your email which presentation you would like to attend.

 

Hemogenyx Pharmaceuticals Limited

www.hemogenyx.com

Peter Redmond, Director

Via Walbrook PR

 

 

Optiva Securities Ltd

Tel: +44 (0)20 3137 1902

Christian Dennis 

 

 

 

Shard Capital Partners LLP

Tel: +44 (0)20 7186 9950

Damon Heath, Erik Woolgar

 

 

 

Peterhouse Corporate Finance Limited

Tel: +44 (0)20 7469 0930

Lucy Williams/Duncan Vasey

 

 

 

Walbrook PR

Tel: +44 (0)20 7933 8780 or hemogenyx@walbrookpr.com

Paul McManus

Mob: +44 (0)7980 541 893

 

 

Flowcomms IR

Mob: +44 (0)7891 627 441 or sasha@flowcomms.com 

Sasha Sethi

                                                                                      

     

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAFNSALLXEAF
UK 100